STAR*D level IV methodology

Am J Psychiatry. 2007 Apr;164(4):681; author reply 681. doi: 10.1176/ajp.2007.164.4.681a.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antidepressive Agents, Second-Generation / therapeutic use
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Cyclohexanols / therapeutic use
  • Depressive Disorder / drug therapy*
  • Depressive Disorder / psychology
  • Drug Therapy, Combination
  • Humans
  • Mianserin / analogs & derivatives
  • Mianserin / therapeutic use
  • Mirtazapine
  • Randomized Controlled Trials as Topic / methods*
  • Research Design / standards
  • Tranylcypromine / therapeutic use
  • Treatment Outcome
  • Venlafaxine Hydrochloride

Substances

  • Antidepressive Agents, Second-Generation
  • Antidepressive Agents, Tricyclic
  • Cyclohexanols
  • Mianserin
  • Tranylcypromine
  • Venlafaxine Hydrochloride
  • Mirtazapine